Anti-angiogenic potential of small molecular inhibitors of cyclin dependent kinases in vitro
✍ Scribed by Stefan Zahler; Johanna Liebl; Robert Fürst; Angelika M. Vollmar
- Book ID
- 106337848
- Publisher
- Springer
- Year
- 2010
- Tongue
- English
- Weight
- 609 KB
- Volume
- 13
- Category
- Article
- ISSN
- 0969-6970
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
The p21 protein is a universal inhibitor of cyclindependent kinases and of cell-cycle progression and is involved in numerous growth-inhibitory pathways in cell culture systems. Recent studies suggest that p21 regulates hepatocyte cell cycle progression in models of liver regeneration. The present s
## Abstract CDK2 inhibitors have been proposed as effective anti‐cancer therapeutics. We show here that CYC202 (__R__‐roscovitine) is a potent inhibitor of recombinant CDK2/cyclin E kinase activity (IC~50~ = 0.10 μM) with an average cytotoxic IC~50~ of 15.2 μM in a panel of 19 human tumour cell lin